Your browser doesn't support javascript.
loading
Recent developments of HDAC inhibitors: Emerging indications and novel molecules.
Bondarev, Andrey D; Attwood, Misty M; Jonsson, Jörgen; Chubarev, Vladimir N; Tarasov, Vadim V; Schiöth, Helgi B.
Afiliación
  • Bondarev AD; Department of Pharmacology, Institute of Pharmacy, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.
  • Attwood MM; Department of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden.
  • Jonsson J; Department of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden.
  • Chubarev VN; Department of Neuroscience, Functional Pharmacology, Uppsala University, Uppsala, Sweden.
  • Tarasov VV; Department of Pharmacology, Institute of Pharmacy, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.
  • Schiöth HB; Department of Pharmacology, Institute of Pharmacy, I. M. Sechenov First Moscow State Medical University, Moscow, Russia.
Br J Clin Pharmacol ; 87(12): 4577-4597, 2021 12.
Article en En | MEDLINE | ID: mdl-33971031
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Rusia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Br J Clin Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Rusia